Cell death-related molecules and biomarkers for renal cell carcinoma targeted therapy
Abstract Renal cell carcinoma (RCC) is not sensitive to conventional radio- and chemotherapies and is at least partially resistant to impairments in cell death-related signaling pathways. The hallmarks of RCC formation include diverse signaling pathways, such as maintenance of proliferation, cell de...
Main Authors: | Yongchang Lai, Tao Zeng, Xiongfa Liang, Weizou Wu, Fangling Zhong, Wenqi Wu |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2019-08-01
|
Series: | Cancer Cell International |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12935-019-0939-2 |
Similar Items
-
Mitochondria and Inflammation: Cell Death Heats Up
by: Esmee Vringer, et al.
Published: (2019-06-01) -
Cancer Cell Growth Inhibitory Effect of Bee Venom via Increase of Death Receptor 3 Expression and Inactivation of NF-kappa B in NSCLC Cells
by: Kyung Eun Choi, et al.
Published: (2014-07-01) -
TRIM27 interacts with Iκbα to promote the growth of human renal cancer cells through regulating the NF-κB pathway
by: Chengwu Xiao, et al.
Published: (2021-07-01) -
Histone Methylation Inhibitor DZNep Ameliorated the Renal Ischemia-Reperfusion Injury via Inhibiting TIM-1 Mediated T Cell Activation
by: Jiawei Li, et al.
Published: (2020-07-01) -
Tumor necrosis factor receptor-associated factor 6 interaction with alpha-synuclein enhances cell death through the Nuclear Factor-kB pathway
by: Lidia M. Yshii, et al.
Published: (2020-12-01)